Iron Deficiency and Iron Deficiency Anemia: Obesity-Associated Complications

The prevalence of obesity continues to rise steadily. Obesity is a well-established leading risk factor for type 2 diabetes and cardiovascular diseases. However, iron deficiency (ID) and iron deficiency anemia (IDA) are far less frequently discussed in the context of obesity-related complications. In obesity, chronic systemic inflammation develops, increasing the production of pro-inflammatory cytokines. This leads to elevated hepcidin levels - a protein that suppresses iron absorption by blocking ferroportin in the duodenum. Among individuals with overweight and obesity, lower serum iron, ferritin, and hemoglobin levels are observed compared to those with normal body weight. Bariatric surgical interventions, aimed at radical obesity treatment, reduce body weight and suppress systemic inflammation. Yet, they simultaneously impair iron absorption due to duodenal bypass, intestinal villous atrophy, and hypochlorhydria, which blocks the conversion of Fe 3+ to bioavailable Fe 2+ , thereby exacerbating iron deficiency. Correction of ID and IDA in obese patients requires a comprehensive approach, including regular monitoring of iron metabolism markers, a diet emphasizing heme iron and vitamin C, and iron supplementation therapy.

Authors

Institutions

Publication Details

Journal
Экспериментальная и клиническая гастроэнтерология
Published
2026-11-18
DOI
https://doi.org/10.31146/1682-8658-ecg-248-4-121-128
Primary Topic
Iron Metabolism and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Iron Deficiency and Iron Deficiency Anemia: Obesity-Associated Complications

Lyudmila A. Sharonova, E. V. Treneva, О В Косарева, Yu. A. Dolgikh et al.
2 links
Экспериментальная и клиническая гастроэнтерология
Iron Metabolism and Disorders
article

Iron Deficiency and Iron Deficiency Anemia: Obesity-Associated Complications

Lyudmila A. Sharonova, E. V. Treneva, О В Косарева, Yu. A. Dolgikh, P. Ya. Merzlova, Dmitrii P. Kurmaev
article en

Abstract

The prevalence of obesity continues to rise steadily. Obesity is a well-established leading risk factor for type 2 diabetes and cardiovascular diseases. However, iron deficiency (ID) and iron deficiency anemia (IDA) are far less frequently discussed in the context of obesity-related complications. In obesity, chronic systemic inflammation develops, increasing the production of pro-inflammatory cytokines. This leads to elevated hepcidin levels - a protein that suppresses iron absorption by blocking ferroportin in the duodenum. Among individuals with overweight and obesity, lower serum iron, ferritin, and hemoglobin levels are observed compared to those with normal body weight. Bariatric surgical interventions, aimed at radical obesity treatment, reduce body weight and suppress systemic inflammation. Yet, they simultaneously impair iron absorption due to duodenal bypass, intestinal villous atrophy, and hypochlorhydria, which blocks the conversion of Fe 3+ to bioavailable Fe 2+ , thereby exacerbating iron deficiency. Correction of ID and IDA in obese patients requires a comprehensive approach, including regular monitoring of iron metabolism markers, a diet emphasizing heme iron and vitamin C, and iron supplementation therapy.

Экспериментальная и клиническая гастроэнтерология(4)
Samara State Medical University (RU)
Good health and well-being
Iron Metabolism and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon